Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1,919.00 |
|---|---|
| Enterprise Value | $3.45 Million |
| Earnings per Share | $-0.01 |
| Beta | -2.03 |
| Outstanding Shares | 19,188,000 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -33.97 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -1.12 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various co...